Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England

Journal of Hospital Infection

Volumn 80, Issue 3, 2012, Pages 229-237

  Jen, M H ^a,b   Saxena, S ^a   Bottle, A ^a   Pollok, R ^c   Holmes, A ^a   Aylin, P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Administrative dataset; Community acquired infection; Hospital episode statistics; Hospital acquired infection

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY; COMMUNITY AQUIRED CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; EMERGENCY PATIENT; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; TREND STUDY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENGLAND; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT ADMISSION; YOUNG ADULT;

EID: 84857138392     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.01.001     Document Type: Article

References (33)

1. Jarvis W.R., Schlosser J., Jarvis A.A., Chinn R.Y. National point prevalence of Clostridium difficile in US health care facility inpatients. Am J Infect Control 2008, 37:263-270.
2. Anonymous Healthcare-associated infections in England: 2008-2009 report 2010, Health Protection Agency, Centre for infections, London.
3. Castagliuolo I., LaMont J.T. Pathophysiology, diagnosis and treatment of Clostridium difficile infection. Keio J Med 1999, 48:169-174.
4. Kuijper E.J., Coignard T.P. Emergence of Clostridium difficile associated disease in North America and Europe. Clin Microbiol Infect 2006, 12:2-18.
5. Zilberberg M.D., Tillotson G.S., McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010, 16:604-609.
6. Anonymous Investigation into outbreaks of Clostridium difficile at Maidstone and Tunbridge Wells NHS Trust 2007, Healthcare Commission, London.
7. Anonymous Clostridium difficile infections fall significantly 2008, Health Protection Agency, Centre for Infections, London.
8. Anonymous Healthcare-associated infections in England: 2008-2009 report 2009, Health Protection Agency, Centre for Infections, London.
9. Anonymous Reducing Healthcare Associated Infection in Hospitals in England. Fifty-second Report of Session 2008-2009 2009, House of Commons PAC, London.
10. Anonymous Weekly infections statistics gives power to patients 2010, Department of Health, London.
11. Cooke R.P., Collins J., Galloway A., Holland D., Trigg G. Audit of the laboratory diagnosis of Clostridium difficile infection in the UK. J Hosp Infect 2010, 75:282-286.
12. Anonymous Quarterly epidemiological commentary: mandatory MRSA bacteraemia & Clostridium difficile infection (October 2007 to December 2009) 2010, Health Protection Agency, Centre for Infections, London.
13. Anonymous Clostridium difficile infection: how to deal with the problem 2008, Department of Health and Health Protection Agency, London.
14. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2009, 8:777-784.
15. Wilcox M.H. Clostridum difficile infection and pseudomembranous colitis. Pract Res Clin Gastroenterol 2003, 17:475-493.
16. Gould D. Prevention and control of Clostridium difficile infection. Nurs Older People 2010, 22:29-34.
17. Vongerg R.P., Kuijper E.J., Wilcox M.H., et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008, 14(Suppl. 5):2-20.
18. Gerding D.N., Muto C.A., Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008, 15(Suppl. 1):43-49.
19. Starr J.M., Rogers T.R., Impallomeni M. Hospital-acquired Clostridium difficile diarrhoea and herd immunity. Lancet 1997, 349:426-428.
20. Bottle A., Aylin P. Intelligent Information: a national system for monitoring clinical performance. Health Serv Res 2008, 43:10-31.
21. Sohn S., Climo M., Diekema D., et al. Varying rates of Clostridium difficile-associated diarrhea at prevention epicentre hospitals. Infect Control Hosp Epidemiol 2005, 26:676-679.
22. Hall I.C., O'Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilus. Am J Dis Child 1935, 49:390-402.
23. Bauer T.M., Lvani A., Fehrenbach J., et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001, 285:313-319.
24. Carstairs V., Morris R. Deprivation and health in Scotland 1991, Aberdeen University Press, Aberdeen.
25. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
26. Jen M.H., Holmes A., Bottle A., Aylin P. Descriptive study of selected healthcare-associated infections using national Hospital Episode Statistics data 1996-2006 and comparison with mandatory reporting systems. J Hosp Infect 2008, 70:321-327.
27. Pituch H. Clostridium difficile is no longer just a nosocomial infection or an infection of adults. Int J Antimicrob Agents 2009, 33:S42-S45.
28. Dubberke E.R., Butler A.M., Yokoe D.S., et al. Multicentre study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010, 31:262-268.
29. Olson M.E.D., Shanholzer C.J., Lee J.T., Gerding D.N. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA medical centre, 1982-1991. Infect Control Hosp Epidemiol 1994, 15:371-381.
30. Spencer R.C. Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 1998, 41:5-12.
31. Berild D., Smaabrekke L., Halvorsen D.S., Lelek M., Stahlsberg E.M., Ringertz S.H. Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals. J Hosp Infect 2003, 54:202-206.
32. Wistrom J., Norrby S.R., Myhre E.B., et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001, 47:43-50.
33. Jobe B.A., Grasley A., Deveny K.E., Deveny C.W., Sheppard B.C. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995, 169:480-483.